Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
"I was wrong to say free, unqualified."
"Happy to entertain opposing points of view."
No, you hit perfect it on your first sentence then kinda went onto oppose yourself.